Novo Nordisk Aktie
60,65
EUR
+0,47
EUR
+0,78
%
62,18
EUR
+2,12
EUR
+3,53
%
Werbung
Novo Nordisk Aktie Analyse
30.10.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
16.10.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
14.10.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
12.10.20 | Novo Nordisk Outperform | Credit Suisse Group | |
09.10.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
09.10.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
11.08.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
10.08.20 | Novo Nordisk Outperform | Credit Suisse Group | |
Werbung
|
|||
07.08.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
07.08.20 | Novo Nordisk Outperform | Bernstein Research | |
07.08.20 | Novo Nordisk Outperform | Credit Suisse Group | |
06.08.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
06.08.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
16.07.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
18.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
16.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
15.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
12.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
12.06.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
11.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
05.06.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
05.06.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
21.05.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
14.05.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
13.05.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
13.05.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
07.05.20 | Novo Nordisk overweight | Barclays Capital | |
07.05.20 | Novo Nordisk Outperform | Credit Suisse Group | |
06.05.20 | Novo Nordisk buy | UBS AG | |
06.05.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
06.05.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
29.04.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
17.04.20 | Novo Nordisk buy | UBS AG | |
15.04.20 | Novo Nordisk buy | UBS AG | |
15.04.20 | Novo Nordisk Outperform | Bernstein Research | |
14.04.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
09.04.20 | Novo Nordisk overweight | Barclays Capital | |
07.04.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
24.03.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
23.03.20 | Novo Nordisk buy | UBS AG | |
18.03.20 | Novo Nordisk Outperform | Bernstein Research | |
17.03.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
17.03.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
17.03.20 | Novo Nordisk overweight | Barclays Capital | |
02.03.20 | Novo Nordisk overweight | Barclays Capital | |
25.02.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
06.02.20 | Novo Nordisk Outperform | Credit Suisse Group | |
06.02.20 | Novo Nordisk overweight | Barclays Capital | |
06.02.20 | Novo Nordisk Outperform | Bernstein Research | |
06.02.20 | Novo Nordisk overweight | JP Morgan Chase & Co. |
Werbung
Werbung